EP2882440
Lyfjasamsetningar sem innihalda B-Raf hindra, EGFR hindra og valkvætt PI3K-alfa hindra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.8.2013EP published:
27.2.2019EP application number:
13748243.6
EP translation filed:
7.5.2019Grant published:
15.6.2019EPO information:
European Patent Register
Max expiry date:
4.8.2033Expiry date:
4.8.2026Next due date:
31.8.2026
Title:
PHARMACEUTICAL COMBINATIONS COMPRISING A B-RAF INHIBITOR, AN EGFR INHIBITOR AND OPTIONALLY A PI3K-ALPHA INHIBITOR
Timeline
Today
5.8.2013EP application
27.2.2019EP Publication
7.5.2019Translation submitted
15.6.2019Registration published
4.8.2026Expires
Owner
Name:
Array Biopharma, Inc.Address:
3200 Walnut Street, 80301, Boulder, CO, US
Inventor
Name:
CAPONIGRO, GiordanoAddress:
CambridgeMassachusetts, US
Name:
STUART, DarrinAddress:
EmeryvilleCalifornia, US
Name:
MOUTOUH-DE PARSEVAL, LaureAddress:
Basel, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261680473 PDate:
7.8.2012Country:
US
Classification
Categories:
A61K 31/506, A61K 31/4439, A61K 31/517, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 18.7.2019
Expires: 4.8.2020
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 10.7.2020
Expires: 4.8.2021
Payer: Örn Þór slf.
Number: 9
Paid: 13.7.2021
Expires: 4.8.2022
Payer: Örn Þór slf.
Number: 10
Paid: 12.7.2022
Expires: 4.8.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 21.6.2023
Expires: 4.8.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 23.7.2024
Expires: 4.8.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 7.8.2025
Expires: 4.8.2026
Payer: Árnason Faktor ehf.